Provider-led I-SNPs have driven down resident hospitalizations, but their effect on other key clinical measures is questionable, a new study shows.
The company announced last fall, however, that it was ending I-SNP coverage in some regions and is facing increasing competition from other, smaller competitors. I-SNP popularity has continued to grow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback